PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
In ApoE-deficient mice, D. odorifera significantly modulated blood lipid levels and alleviated intimal hyperplasia [PMID:38387125]
Leaf extract administered via gastric infusion led to the alleviation of brain edema in a middle cerebral artery occlusion/reperfusion model [PMID:41253024]
Flavonoids reduced myocardial enzymes and oxidative stress markers while reducing pathologic changes in heart tissue [PMID:38066409]
Certain flavonoid derivatives exhibited significant inhibition of nitric oxide production in LPS-stimulated RAW264.7 cells [PMID:35822397]
Specific sesquiterpenoids showed inhibitory effects against Candida albicans and Staphylococcus aureus [PMID:24613800]
Evidence summary
PubMed sources
- 1.PMID: 31654799 (2020) — Dalbergia odorifera: A review of its traditional uses, phytochemistry, pharmacology, and quality control. · Journal of ethnopharmacology
- 2.PMID: 41253024 (2025) — Dalbergia odorifera T.C. Chen leaf extract promotes microglial energy expenditure to phagocytize neutrophils after cerebral ischemia-reperfusion. · Phytomedicine : international journal of phytotherapy and phytopharmacology
- 3.PMID: 34536995 (2021) — A complete mitochondrial genome for fragrant Chinese rosewood (Dalbergia odorifera, Fabaceae) with comparative analyses of genome structure and intergenomic sequence transfers. · BMC genomics
- 4.PMID: 32808664 (2020) — The chromosome-level draft genome of Dalbergia odorifera. · GigaScience
- 5.PMID: 29348771